Skip to main content
. 2023 Feb 12;23:63. doi: 10.1186/s12905-022-02140-y

Table 3.

Baseline characteristics of cases and controls groups among low and high adherence of DASH diet

Control Case
Low (n = 37) High (n = 68) P value P value* Low (n = 72) High (n = 33) P value P value*
Demographic characteristic
Age (y) 54.06 ± 6.555 56.12 ± 7.428 0.16 55.44 ± 7.082 54.76 ± 7.483 0.65
Albumin (g/dl) 12.58 ± 7.602 6.11 ± 5.097  < 0.001  < 0.001 15.56 ± 13.158 13.09 ± 10.001 0.34 0.34
ACR 19.65 ± 6.212 18.09 ± 5.766 0.20 0.07 239.74 ± 91.266 217.67 ± 145.891 0.35 0.42
Diabetes duration (y) 7.67 ± 2.111 7.49 ± 2.222 0.70 7.65 ± 2.184 7.50 ± 2.305 0.75
Blood pressure
SBP (mmHg) 121.72 ± 16.554 133.00 ± 122.428 0.58 0.69 128.61 ± 16.597 123.64 ± 19.272 0.18 0.08
DBP (mmHg) 81.53 ± 13.064 79.25 ± 11.096 0.35 0.67 84.83 ± 14.064 78.33 ± 9.746 0.01 0.04
Anthropometry characteristic
Body weight (kg) 69.686 ± 12.9626 72.722 ± 10.6348 0.20 0.30 73.561 ± 12.4596 72.182 ± 16.2292 0.64 0.63
Height (cm) 163.36 ± 4.673 159.93 ± 6.177 0.004  < 0.001 160.35 ± 6.348 161.79 ± 6.294 0.28 0.36
BMI (kg/m2) 26.028 ± 4.9568 28.367 ± 3.8442 0.009 0.07 28.586 ± 4.7848 28.356 ± 3.9868 0.81 0.79
Blood parameters
Hb (mg/dl) 12.456 ± 1.2796 12.753 ± 1.1719 0.23 0.19 12.439 ± 1.3583 13.112 ± 1.3188 0.02 0.18
FBS (mg/dl) 161.92 ± 45.779 149.81 ± 44.668 0.19 0.57 168.71 ± 53.292 160.79 ± 47.320 0.47 0.03
BS (mg/dl) 217.22 ± 52.193 201.62 ± 55.460 0.16 0.36 220.26 ± 58.710 210.42 ± 43.663 0.39 0.07
HbA1c (%) 8.44 ± 1.21 7.79 ± 1.28 0.01 0.10 8.74 ± 1.38 8.33 ± 1.44 0.17 0.02
Cholesterol (mg/dl) 180.69 ± 25.829 172.26 ± 35.373 0.21 0.39 187.83 ± 36.408 183.45 ± 41.200 0.59 0.87
TG (mg/dl) 164.31 ± 49.132 159.75 ± 61.630 0.70 0.87 163.83 ± 56.674 171.91 ± 81.388 0.56 0.41
LDL (mg/dl) 103.97 ± 29.577 89.10 ± 28.167 0.01 0.10 108.80 ± 33.345 103.73 ± 27.924 0.45 0.91
HDL (mg/dl) 46.00 ± 8.903 46.59 ± 9.553 0.76 0.93 44.88 ± 9.421 43.82 ± 8.041 0.58 0.87
Cr (mg/dl) 0.86 ± 0.14 0.87 ± 0.18 0.79 0.03 0.9480 ± 0.16718 0.8679 ± 0.14339 0.02 0.18
BUN (mg/dl) 16.50 ± 4.398 14.43 ± 3.374 0.009 0.007 15.67 ± 4.086 15.76 ± 5.657 0.93 0.89
Qualitative variables
PA (met-h/w)
 Low (> 600) 13 (35.1) 24 (64.9) 0.79 20 (66.7) 10 (33.3) 0.89
 Moderate (600–3000) 9 (29.6) 19 (70.4) 33 (67.5) 13 (32.5)
 High (< 3000) 15 (37.5) 25 (62.5) 19 (66.5) 10 (34.5)
Medical history
Positive CVD history 10 (43.5) 13 (56.5) 0.31 14 (63.6) 8 (36.4) 0.73
Medication usage
ARBs 16 (35.6) 29 (64.4) 0.86 36 (64.3) 20 (35.7) 0.56
ACEIs 9 (45) 11 (55) 0.27 29 (67.4) 14 (32.6) 0.88
Beta blockers 7 (38.9) 11 (61.1) 0.67 13 (68.4) 6 (31.6) 0.36
Metformin 35 (34) 68 (66) 0.34 65 (66.3) 33 (33.7) 0.99
sulfonylurea 22 (36.1) 39 (63.9) 0.71 43 (65.2) 23 (34.8) 0.65
Insulin 12 (34.3) 23 (65.7) 0.96 20 (76.9) 6 (23.1) 0.19

Data are presented as mean ± SD or number (percent). Low and high adherence of median of DASH diet are shown

Independent sample T test and chi square were used

Significant items with a P value ≤ 0.05 are bolded

ACR Albumin creatinine ratio, SBP Systolic blood pressure, DBP Diastolic blood pressure, BMI Body mass index, Hb Hemoglobin, FBS Fasting blood sugar, BS Blood sugar, TG Triglycerides, HDL High density lipoprotein, LDL Low density lipoprotein, CR Creatinine, BUN Blood urea nitrogen, CVD Cardiovascular disease, ARBs Angiotensin receptor blockers, ACEIs Angiotensin converting enzyme inhibitors

*Adjusted for age, energy intake, physical activity